Cardiologia
Revisão | Manejo de vias aéreas durante a ressuscitação cardiopulmonar.
8 Set, 2022 | 13:36hAirway Management During Cardiopulmonary Resuscitation – Current Anesthesiology Reports
Diretriz de consenso | Manejo pré-operatório de medicamentos cardiovasculares.
6 Set, 2022 | 13:16hConteúdos relacionados:
Preoperative Management of Medications for Neurologic Diseases – Mayo Clinic Proceedings
Preoperative Management of Surgical Patients Using Dietary Supplements – Mayo Clinic Proceedings
Perioperative Evaluation and Management of Endocrine Disorders – Mayo Clinic Proceedings
Preoperative Cardiac Risk Assessment – Mayo Clinic Proceedings
Preoperative Evaluation Before Noncardiac Surgery – Mayo Clinic Proceedings
Perioperative Cardiac Risk Reduction in Noncardiac Surgery – Mayo Clinic Proceedings
Perioperative Venous Thromboembolism Prophylaxis – Mayo Clinic Proceedings
Estudo de coorte | Ingestão habitual de álcool e risco de fibrilação atrial em adultos jovens.
6 Set, 2022 | 13:07hHabitual Alcohol Intake and Risk of Atrial Fibrillation in Young Adults in Korea – JAMA Network Open
Comentário convidado: Self-reported Alcohol Consumption and Risk of Atrial Fibrillation – JAMA Network Open
Revisão | Função ventricular direita ao longo do espectro de saúde e doença.
6 Set, 2022 | 13:03hRight ventricular function across the spectrum of health and disease – Heart
Comentário no Twitter
Right ventricular function across the spectrum
of health and disease https://t.co/3i9iiddsyV #echofirst #Cardiotwitter #CardioEd #MedEd #CardioTwitteros pic.twitter.com/Q219nvnu6v— Sergio Moreno M (@Serginho1409) July 11, 2022
Sob licença de http://creativecommons.org/licenses/by-nc/4.0/
Estudo randomizado | Autoaferição de pressão arterial com um dispositivo padrão não é melhorada pelo uso de um aplicativo de smartphone.
29 Ago, 2022 | 17:57hEffectiveness of Standard vs Enhanced Self-measurement of Blood Pressure Paired With a Connected Smartphone Application: A Randomized Clinical Trial – JAMA Internal Medicine (link para o resumo – $ para o texto completo)
Comunicado de imprensa: For Checking Blood Pressure at Home, Basic Cuffs Are Just as Good – UC San Francisco
Comentário: App-enabled device no better than standard device for self-measuring blood pressure – ACP Internist
Comentário no Twitter
Monitoring #bloodpressure at home may help with #bloodpressurecontrol, but using an enhanced device pairing with a smartphone application appears to be no more effective than using a standard device. https://t.co/h6zREImCNv #Research pic.twitter.com/T1zWDlp2pC
— JAMA Internal Medicine (@JAMAInternalMed) August 15, 2022
Metanálise de rede | Terapia antitrombótica para doença arterial periférica sintomática.
29 Ago, 2022 | 17:55h
Revisão | Valor adicional de escores de risco poligênico na prevenção primária de doença cardíaca coronariana.
29 Ago, 2022 | 17:53hIncremental Value of Polygenic Risk Scores in Primary Prevention of Coronary Heart Disease: A Review – JAMA Internal Medicine (gratuito por tempo limitado)
Conteúdos relacionados:
Cohort Study | Polygenic risk, midlife life’s simple 7, and lifetime risk of stroke.
AHA Scientific Statement | Polygenic risk scores for cardiovascular disease.
Cohort Study: A polygenic risk score may improve risk stratification of coronary artery disease.
Responsible use of polygenic risk scores in the clinic: potential benefits, risks and gaps.
Análise secundária de um estudo randomizado | Efeitos da empagliflozina sobre sintomas, limitações físicas e qualidade de vida de pacientes internados com insuficiência cardíaca aguda.
29 Ago, 2022 | 17:50hComentário: Empagliflozin Offers Clinical Benefit in Heart Failure – HealthDay
Estudo original: The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial – Nature Medicine
Análise de especialista | Aplicações clínicas da ressonância magnética em doenças pericárdicas.
29 Ago, 2022 | 17:06hConteúdo relacionado: Case Series: Cardiac magnetic resonance in the assessment of pericardial abnormalities.
Estudo observacional sugere que a hidroxicloroquina está associada com risco aumentado de eventos cardiovasculares em comparação ao metotrexato em pacientes com insuficiência cardíaca.
29 Ago, 2022 | 17:03hCardiovascular Risks of Hydroxychloroquine vs Methotrexate in Patients With Rheumatoid Arthritis – Journal of the American College of Cardiology (link para o resumo – $ para o texto completo)
Editorial: Hydroxychloroquine: Heart-Throb No More? – Journal of the American College of Cardiology
Comentário: Caution needed with hydroxychloroquine use in older RA patients with heart failure – medwire News